Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-20-032142
Filing Date
2020-05-26
Accepted
2020-05-26 17:54:57
Documents
1
Period of Report
2019-12-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4417
  Complete submission text file 0001209191-20-032142.txt   5830
Mailing Address 3450 MONTE VILLA PARKWAY BOTHELL WA 98011
Business Address
Kaye Edward M. MD (Reporting) CIK: 0001522780 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38938 | Film No.: 20912117

Mailing Address 3 PRESTON COURT BEDFORD MA 01730
Business Address 3 PRESTON COURT BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

EIN.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations